4.7 Review

Targeting ITK signaling for T cell-mediated diseases

Journal

ISCIENCE
Volume 24, Issue 8, Pages -

Publisher

CELL PRESS
DOI: 10.1016/j.isci.2021.102842

Keywords

-

Funding

  1. National Blood Foundation Scholar Award
  2. National Institutes of Health (NIH) [L6 MD0010106, K22 (AI130182)]
  3. Upstate Medical University Cancer grant [1146249-1-75632]

Ask authors/readers for more resources

This review explores the role of ITK signaling in multiple diseases, including T cell-derived malignancies, allergic diseases, infectious diseases, autoimmune disorders, and the potential use of ITK inhibition in transplantation recipients.
The focus of this review is to examine the role of ITK signaling in multiple diseases and investigate the clinical potential of ITK inhibition. The diseases and potential interventions reviewed include T cell-derived malignancies as well as other neoplastic diseases, allergic diseases such as asthma and atopic dermatitis, certain infectious diseases, several autoimmune disorders such as rheumatoid arthritis and psoriasis, and finally the use of ITK inhibition in both solid organ and bone marrow transplantation recipients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available